Infinity Pharmaceuticals Inc at 2020 San Antonio Breast Cancer Symposium - Conference Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Infinity Pharmaceuticals 2020 San Antonio Breast Cancer Symposium. (Operator Instructions) I would now like to introduce host of today's conference call, Ms. Jayne Kauffman. You may begin.
Good morning, everyone, and welcome to today's call where we will review TNBC data from MARIO-3, which was presented today during the San Antonio Breast Cancer Symposium, or SABC.
Participants on today's call are Adelene Perkins, Chief Executive Officer; and Dr. Brian Schwartz, Consulting Chief Physician from Infinity Pharmaceuticals; and Dr. Erika Hamilton, Director of the Breast Cancer and Gynecologic Cancer Research Program at Sarah Cannon Research Institute at Tennessee Oncology; and MARIO-3 Lead Study Investigator.
During this call, we may make forward-looking statements about our future expectations and plans including clinical development objectives, the therapeutic potential of our product candidates, our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |